Frédérique Menzaghi
2020
In 2020, Frédérique Menzaghi earned a total compensation of $1.4M as Chief Scientific Officer and Senior Vice President, Research and Development at Cara Therapeutics, a 38% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $323,349 |
|---|---|
| Option Awards | $344,042 |
| Salary | $451,200 |
| Stock Awards | $261,760 |
| Other | $10,959 |
| Total | $1,391,310 |
Menzaghi received $451.2K in salary, accounting for 32% of the total pay in 2020.
Menzaghi also received $323.3K in non-equity incentive plan, $344K in option awards, $261.8K in stock awards and $11K in other compensation.
Rankings
In 2020, Frédérique Menzaghi's compensation ranked 7,175th out of 13,090 executives tracked by ExecPay. In other words, Menzaghi earned more than 45.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,175 out of 13,090 | 45th |
Division Manufacturing | 2,999 out of 5,621 | 47th |
Major group Chemicals And Allied Products | 1,211 out of 2,254 | 46th |
Industry group Drugs | 1,044 out of 1,954 | 47th |
Industry Pharmaceutical Preparations | 778 out of 1,459 | 47th |
Source: SEC filing on April 23, 2021.
Menzaghi's colleagues
We found four more compensation records of executives who worked with Frédérique Menzaghi at Cara Therapeutics in 2020.
News
Cara Therapeutics CEO Derek Chalmers' 2021 pay jumps 250% to $10M
April 22, 2022
Cara Therapeutics CEO Derek Chalmers' 2020 pay slips 15% to $2.9M
April 23, 2021
Cara Therapeutics CEO Derek Chalmers' 2019 pay jumps 23% to $3.4M
April 22, 2020
Cara Therapeutics Chief Medical Officer Joana Goncalves receives $3.7M in 2018
April 24, 2019